Invasive Aspergillosis
📧 Sign up to get email alerts when something new happens for Invasive Aspergillosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-05-09FDA Approved: VORICONAZOLE — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' original application for a generic voriconazole product, enabling marketing of a generic antifung…
-
FDA approval · 2022-02-17FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for CRESEMBA (isavuconazonium sulfate) submitted by Astellas Pharma US, expanding the approval throu…
-
FDA approval · 2022-02-17FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) filed by Astellas Pharma US, expanding its approved use.
-
FDA approval · 2021-12-14FDA Approved: AMPHOTERICIN B — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' original application for Amphotericin B, confirming a generic version of the antifungal. The…
-
FDA approval · 2021-12-09FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) submitted by Astellas Pharma US, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-05-18FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) filed by Astellas Pharma US, Inc. The approval adds to the ex…
-
FDA approval · 2021-04-22FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved Astellas' supplemental application for Cresemba (isavuconazonium sulfate), finalizing changes to its labeling. The action u…
-
FDA approval · 2021-02-01FDA Approved: POSACONAZOLE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved the original application for posaconazole from Lupin Pharmaceuticals, enabling generic availability of the antifungal.
-
FDA approval · 2020-09-16FDA Approved: NOXAFIL — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved Merck's supplemental application for NOXAFIL (posaconazole), updating the product labeling with new indications/usage detai…
-
FDA approval · 2018-11-30FDA Approved: VORICONAZOLE — Original Application (Slate Run Pharmaceuticals)
FDA approved voriconazole under an original application for Slate Run Pharmaceuticals.
-
FDA approval · 2018-03-13FDA Approved: CANCIDAS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approves a supplemental application for Cancidas (caspofungin acetate) to update labeling and/or expand its indications, as part of Merc…
-
FDA approval · 2017-03-09FDA Approved: VORICONAZOLE — Original Application (Xellia Pharmaceuticals USA LLC)
FDA approved voriconazole via an Original Application submitted by Xellia Pharmaceuticals USA LLC (NDA208562).
-
FDA approval · 2016-05-31FDA Approved: VORICONAZOLE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approval of Lupin's original application for a generic voriconazole product used to treat invasive fungal infections, including invasive…
-
FDA approval · 2016-05-24FDA Approved: VORICONAZOLE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for Voriconazole from Zydus Lifesciences Limited, granting approval for a generic Voriconazole product…
-
FDA approval · 2016-05-24FDA Approved: VORICONAZOLE — Original Application (Ajanta Pharma USA Inc.)
FDA approved a generic version of voriconazole from Ajanta Pharma USA Inc. under an Original Application, for treatment of invasive aspergil…
-
FDA approval · 2016-05-24FDA Approved: VORICONAZOLE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' generic voriconazole through an Original Application (ANDA); the product is indicated for treating invas…
-
FDA approval · 2016-04-13FDA Approved: VORICONAZOLE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's original-application generic Voriconazole (voriconazole) for its approved antifungal indications.
-
FDA approval · 2016-01-22FDA Approved: VORICONAZOLE — Original Application (Aurobindo Pharma Limited)
FDA approved Voriconazole from Aurobindo Pharma Limited via an Original Application (ANDA), introducing a generic version of voriconazole. T…
-
FDA approval · 2016-01-12FDA Approved: VORICONAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Voriconazole submitted by Mylan Pharmaceuticals.
-
FDA approval · 2016-01-05FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) from Astellas Pharma US, expanding its approved indications. …
-
FDA approval · 2015-10-23FDA Approved: VORICONAZOLE — Supplemental Application (Sandoz Inc)
FDA approves a supplemental application for voriconazole (VORICONAZOLE) from Sandoz Inc.
-
FDA approval · 2015-09-02FDA Approved: VORICONAZOLE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original application for a generic Voriconazole (ANDA 203503), enabling the generic antifungal to be marketed in…
-
FDA approval · 2015-04-03FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for CRESEMBA (isavuconazonium sulfate) from Astellas Pharma US, Inc., to support changes to the prod…
-
FDA approval · 2015-03-06FDA Approved: CRESEMBA — Original Application (Astellas Pharma US, Inc.)
FDA approves Cresemba (isavuconazonium sulfate) under an original application for the treatment of invasive aspergillosis and mucormycosis.
-
FDA approval · 2015-03-06FDA Approved: CRESEMBA — Original Application (Astellas Pharma US, Inc.)
FDA approved CRESEMBA (isavuconazonium sulfate) from Astellas Pharma US, Inc. as an antifungal treatment. The approval covers invasive asper…